Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

Moderna Inc., consolidated statement of comprehensive income

US$ in millions

12 months ended:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income (loss)	(4,714)	8,362)	12,202)	(747)	(514)
Unrealized gains (losses) on available-for-sale debt securities	210)	(348)	(42)	3)	3)
Net realized (gains) losses on available-for-sale securities reclassified to net income (loss)	38)	26)	(1)	(1)	—)
Net increase (decrease) from available-for-sale debt securities	248)	(322)	(43)	1)	3)
Unrealized gains (losses) on derivative instruments	—)	130)	74)	—)	—)
Net realized (gains) losses on derivative instruments reclassified to net income (loss)	8)	(154)	(58)	—)	—)
Net increase (decrease) from derivatives designated as hedging instruments	8)	(24)	16)	—)	—)
Pension and postretirement obligation adjustments	(9)	—)	—)	—)	—)
Pension and postretirement benefit plans	(9)	—)	—)	—)	—)
Other comprehensive income (loss), net of tax	247)	(346)	(27)	1)	3)
Comprehensive income (loss)	(4,467)	8,016)	12,175)	(746)	(511)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Download chart

Comprehensive income item	Description	The company
Net income (loss)	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	Moderna Inc. net income (loss) decreased from 2021 to 2022 and from 2022 to 2023.
Comprehensive income (loss)	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners.	Moderna Inc. comprehensive income (loss) decreased from 2021 to 2022 and from 2022 to 2023.

Moderna Inc. (NASDAQ:MRNA)

Statement of Comprehensive Income